Introduction

FACT: 50-60 million people are infected with genital herpes (HSV-2) today in the United States.

FACT: 90% of them don't know they have HSV-2.

Who's at Risk?
o Any patient at risk for sexually transmitted diseases (STD) including HIV.
o People who have a history of symptoms suggestive of genital herpes.

About Genital Herpes
Genital herpes is a sexually transmitted disease caused by the herpes simplex viruses type 1 (HSV-1) and type 2 (HSV-2).

Over 80% of recurring genital herpes is due to HSV-2. Type-specific serology has been shown to be the best way to detect persons with subclinical or recurring genital herpes.

The CDC recommends that at risk patients be offered type-specific serology tests to accurately distinguish between HSV-1 and HSV-2 infections.

Once HSV-2 is diagnosed by testing, therapy can suppress HSV-2, reduce painful outbreaks, and decrease the risk of transmitting HSV-2 to a partner.

Testing and treatment may also reduce the risk of acquiring HIV or experiencing HIV progression.

A type-specific gG-2 immunoassay kit is a leading aid in the diagnosis of genital herpes. Only glycoprotein G (gG-2) based assays have been shown to be accurate in detecting antibodies to HSV-2.

>